Paraplegic patients have intractable constipation associated with prolonged colonic transit time. The agent Cisapride significantly reduced the colonic transit time from 7.7 days to 5.1 days. It also improved the intraluminal tone in the rectum, resulting in a significant reduction in maximal rectal capacity from 305.8 ml to 224.3 mi.
Methods
When patients entered the trial, the extent of their constipation was determined by first establishing their intestinal transit times. The 10 subjects were fasted for a control period of at least 8 hours before being given an intravenous injection of 10 mg cisapride. Rectal capacity and pressure studies done in the control period were now repeated. After an interval of at least 48 hours the subject was commenced on oral cisapride 10 mg 8 hourly. This was taken for 48 hours before the transit times were repeated. The cisapride was continued until each transit time estimation was complete. At this time blood tests and residual urine volumes were repeated.
Gastrointestinal transit time
The Oro-Caecal Transit Time (OCT) was estimated using the oral lactulose and expired breath hydrogen method (Bond 1975) . A sample of end expiratory breath is taken as a baseline level of breath hydrogen. The subject swallows 10 g of lactulose with a standard breakfast of 500 cal, having fasted for 8 hours.
Thereafter the breath is sampled every 15 minutes until the rise in hydrogen due to the lactulose reaching the caecum is observed. The Oro-Anal Transit Time (OAT) is estimated using radio-opaque polythene markers and X-raying of the stools (Hinton 1969) . This allows a reasonable measure of transit time and avoids unnecessary exposure of the subject to X-rays. The Colonic-Transit Time (CTT) was calculated by subtracting the OCT from the OAT.
The method of stool collection was by manual rectal evacuation with the occasional spontaneous evacuation. A digital rectal examination was performed each morning after breakfast and any rectal contents were evacuated into the collection bag. The patients were divided into two groups of five subjects. The group with spinal lesions C4 to C7 had the rectal examination and evacuation performed by an attendant while the second group with lesions T3 to TI0 were able to perform the examinations and evacuations themselves.
Anal sphincter studies
The functional Sphincter Length (SL) of the combined internal and external anal sphincter was recorded in increments of 1 cm together with the maximum resting pressure (MRP) . The Recto-Anal Sphincteric Inhibitory Reflex (RSR) (Gowers 1877 , Henry 1985 records the reflex induced fall in pressure due to the internal anal sphincter relaxing on rapid distention of the rectum with 50 ml of air.
Electrophysiological studies
The integrity and latency of the Pudendo-Anal Reflex (PAR) involves a minor electrical stimulus over the dorsal genital nerve while recording from an anal plug electrode. Using this same anal plug electrode as a stimulating electrode, the integrity and latency of conduction in the spinal cord can be assessed by recording Somatosensory Cerebral Evoked Potentials (SSEP) with scalp electrodes (Lehmkull 1986).
Proctometrogram
The rectal capacity (MAXV) and rise in intraluminal pressure (MAXP) as changes in rectal volume are achieved is derived by this technique (Varma 1986) . A large compliant rectal balloon is distended at a rate of 67 mljmin while the pressure in the balloon is recorded by a second device.
The point of spontaneous expulsion of the rectal balloon or the detection of autonomic dysreftexia is taken as being at maximal rectal capacity. The ratio of MAXV to MAXP (RATIO V jP) gives an indication of the distensibility of the rectum.
Pulse rate and blood pressure
These were recorded when intravenous cisapride was given and continued every 5 minutes for up to 30 minutes afterwards. The recordings were taken from the brachial pulse just proximal to the antecubital fossa with a Dynamap automatic pneumatic cuff recording device.
Blood count, urea electrolytes and liver Junction
These tests were carried out in the hospital laboratories in the normal way.
Residual urine volume
This was carried out in the subjects who did not have an indwelling catheter, both before and during administration of oral cisapride (RUV).
Faecal water content
The percentage water content (%H20) of the faeces was derived by weighing the samples before and after a freeze drying technique (Eastwood 1984) .
Transit marker dispersion
The number of separate stools containing transit marker pellets (STM) was recorded for each subject, giving an indication of intraluminal mixing.
Statistical analysis
Statistical significance was determined by a t test after logarithmic conversion of the data.
Results
The results are given in the rectal pressure. All three achieved statistical significance with p < 0.001, p < 0.005 and p < 0.005 respectively. The colonic transit time was reduced from 185 hours to 123 hours, the maximum rectal volume was reduced from 305 ml to 224 ml and the ratio of miximum rectal volume to maximum rectal pressure was reduced from 4.3 to 3.1. The faecal water remained unchanged.
Stool mixing of markers was increased from 1.9 to 3.1 stools.
Discussion
The colon has an intrinsic myenteric nerve plexus which has a degree of spontaneous activity and causes autonomous colonic muscle activity (Christensen 1981) . This myenteric plexus can also be stimulated by the extrinsic nerve supply of the colon (Bayliss 1900; Wood 1981) . The constipation in spinal injury subjects may be due to interruption, at the spinal level, of the extrinsic nerve supply to the distal colon. The extrinsic parasympathetic nerve supply to the distal colon emerges from the central nervous system with the anterior sacral roots S 2, 3 and 4. Direct electrical stimulation of these sacral nerve roots has been shown to affect the pelvic colon and ano-rectal function (Varma and Binnie et al., 1986) . As neuroprosthetic stimulation to increase the activity of the colon is not yet as appropriate as its use for bladder stimulation, a suitable pharmacological preparation capable of stimulating intestinal motility would have more immediate application. The agent cisapride is a synthetic substituted benzamide which has been shown to have a potent stimulation effect on isolated rabbit colonic smooth muscle, probably through a muscarinic receptor (Snape 1985) . There is a similar effect on guinea pig ileum. Using binding studies for dopamine receptors on rat striatum and when tested against apomorphine induced vomltlng in dogs, there was no anti-dopaminergic properties (Van Nueten 1985) . The effect on motor activity may be mediated in part by blocking type 2 serotonin receptors (Moriarty 1985) and the possible release of other gastrointestinal hormones (Koop 1986 ). The action of this agent has been studied in humans, on oesophageal motility (Wienbeck 1984; Corazziari 1985; Smout 1985) . These authors have shown that this agent reduces gastro-oeso phageal reflux by increasing the pressure in the region of the gastro-oesophageal junction. In gastric motility (Jian 1985; Thomforde 1985; Edwards 1987) cisapride stimulates gastric emptying. As a consequence of jejunal activity (Stacher 1986 ) and stimulation of colonic motility (Miller-Lissner 1985; Lee 1984; Lederer 1985) it is said to reduce transit time.
The present study shows that in spinal injured subjects cisapride significantly reduces both colonic transit time and the maximum rectal capacity. The intraluminal mixing of contents is increased, as detected by the increased dispersion of markers in stool collections. The faecal water content is little changed. The internal anal sphincter reflex relaxation caused by rectal distention is not inhibited by cisapride. There appeared to be no adverse effects on heart rate or blood pressure although there was a slight reduction in diastolic pressure.
No side effects on parameters of full blood count, urea, electrolytes and liver function tests were noted. In the first patient, who normally emptied his bladder by suprapubic tapping, the unwanted side effect of acute retention of urine was noted on the morning after abrupt cessation of oral cisapride. This resolved after 1 day of intermittent catheterisation. In subsequent subjects the cisapride was tailed off at 10 mg twice and 10 mg once per day for 1 day each before stopping the drug completely. A reduction in residual volume while taking cisapride was noted in 7 of the remaining subjects but a more formal study would be required to determine the significance, if any, of this finding.
Regarding the long-term effects of cisapride, there are to date several subjects, including 2 from this study, who have taken the drug for periods in excess of 1 year. The beneficial effects on colonic function are maintained and will be formally reported at a later date. We have not detected any deleterious long term effects of oral cisapride 10 mg thrice daily on modalaties of blood pressure or heart rate, full blood count, urea, electrolytes and liver function tests. We did however record 1 case of retention of urine after abrupt cessation of the drug and we have subsequently recorded increased frequency of micturition in 3 subjects with incomplete spinal lesions being treated with cisapride for colonic transit problems. This increased frequency was troublesome in 1 female subject and was corrected by reducing the dosage of cisapride to 10 mg twice per day.
